Report Summary
Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
In 2020, the global Cancer Hormone Therapy Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Cancer Hormone Therapy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Hormone Therapy Drugs development in United States, Europe and China.
The key players covered in this study
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
Market segment by Type, the product can be split into
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
Market segment by Application, split into
Breast Cancer
Prostate Cancer
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Hormone Therapy Drugs status, future forecast, growth opportunity, key market and key players.
To present the Cancer Hormone Therapy Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Hormone Therapy Drugs are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (2017-2027)
1.4.2 Tamoxifen
1.4.3 Aromatase Inhibitors
1.4.4 Antiandrogens
1.4.5 Androgen Synthesis Inhibitors
1.4.6 Other
1.5 Market by Application
1.5.1 Global Cancer Hormone Therapy Drugs Market Share by Application (2017-2027)
1.5.2 Breast Cancer
1.5.3 Prostate Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Hormone Therapy Drugs Market Size
2.2 Cancer Hormone Therapy Drugs Growth Trends by Regions
2.2.1 Cancer Hormone Therapy Drugs Market Size by Regions (2017-2027)
2.2.2 Cancer Hormone Therapy Drugs Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Hormone Therapy Drugs Market Size by Manufacturers
3.1.1 Global Cancer Hormone Therapy Drugs Revenue by Manufacturers (2017-2020)
3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
3.3 Key Players Cancer Hormone Therapy Drugs Product/Solution/Service
3.4 Date of Enter into Cancer Hormone Therapy Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Hormone Therapy Drugs Market Size by Type (2017-2020)
4.2 Global Cancer Hormone Therapy Drugs Market Size by Application (2017-2020)
5 United States
5.1 United States Cancer Hormone Therapy Drugs Market Size (2017-2020)
5.2 Cancer Hormone Therapy Drugs Key Players in United States
5.3 United States Cancer Hormone Therapy Drugs Market Size by Type
5.4 United States Cancer Hormone Therapy Drugs Market Size by Application
6 Europe
6.1 Europe Cancer Hormone Therapy Drugs Market Size (2017-2020)
6.2 Cancer Hormone Therapy Drugs Key Players in Europe
6.3 Europe Cancer Hormone Therapy Drugs Market Size by Type
6.4 Europe Cancer Hormone Therapy Drugs Market Size by Application
7 China
7.1 China Cancer Hormone Therapy Drugs Market Size (2017-2020)
7.2 Cancer Hormone Therapy Drugs Key Players in China
7.3 China Cancer Hormone Therapy Drugs Market Size by Type
7.4 China Cancer Hormone Therapy Drugs Market Size by Application
8 Japan
8.1 Japan Cancer Hormone Therapy Drugs Market Size (2017-2020)
8.2 Cancer Hormone Therapy Drugs Key Players in Japan
8.3 Japan Cancer Hormone Therapy Drugs Market Size by Type
8.4 Japan Cancer Hormone Therapy Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Hormone Therapy Drugs Market Size (2017-2020)
9.2 Cancer Hormone Therapy Drugs Key Players in Southeast Asia
9.3 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Type
9.4 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Application
10 India
10.1 India Cancer Hormone Therapy Drugs Market Size (2017-2020)
10.2 Cancer Hormone Therapy Drugs Key Players in India
10.3 India Cancer Hormone Therapy Drugs Market Size by Type
10.4 India Cancer Hormone Therapy Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Hormone Therapy Drugs Market Size (2017-2020)
11.2 Cancer Hormone Therapy Drugs Key Players in Central & South America
11.3 Central & South America Cancer Hormone Therapy Drugs Market Size by Type
11.4 Central & South America Cancer Hormone Therapy Drugs Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Hormone Therapy Drugs Introduction
12.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.1.5 Roche Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Hormone Therapy Drugs Introduction
12.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.2.5 Amgen Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Hormone Therapy Drugs Introduction
12.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.3.5 Pfizer Recent Development
12.4 Teva
12.4.1 Teva Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Hormone Therapy Drugs Introduction
12.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.4.5 Teva Recent Development
12.5 Takeda
12.5.1 Takeda Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Hormone Therapy Drugs Introduction
12.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.5.5 Takeda Recent Development
12.6 Samyang Biopharmaceuticals
12.6.1 Samyang Biopharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Hormone Therapy Drugs Introduction
12.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.6.5 Samyang Biopharmaceuticals Recent Development
12.7 Tolmar
12.7.1 Tolmar Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Hormone Therapy Drugs Introduction
12.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.7.5 Tolmar Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Hormone Therapy Drugs Introduction
12.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.8.5 AstraZeneca Recent Development
12.9 Novartis
12.9.1 Novartis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Hormone Therapy Drugs Introduction
12.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.9.5 Novartis Recent Development
12.10 Aspen
12.10.1 Aspen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Hormone Therapy Drugs Introduction
12.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2017-2020)
12.10.5 Aspen Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
